GeoVax Labs Warrants
GOVXW
GOVXW was delisted on the 26th of September, 2025.
3 hedge funds and large institutions have $8.81K invested in GeoVax Labs Warrants in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
22% less capital invested
Capital invested by funds: $11.2K → $8.81K (-$2.43K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
-$1.33K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$73 |
| 3 |
CS
Clear Street
New York
|
-$21 |
GOVXW Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q3 2024, worth a combined $8.81K — down 22% from $11.2K a quarter earlier.
Fund positioning in GOVXW was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.33K. The largest seller was Marex Group, cutting an estimated $1.33K.
- 3 institutional investors held GeoVax Labs Warrants (GOVXW) as of Q3 2024, down from 4 in Q2 2024.
- Funds reported $8.81K of GeoVax Labs Warrants stock for Q3 2024, down 22% quarter-over-quarter.
- 2 funds opened new GeoVax Labs Warrants positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest GeoVax Labs Warrants buyer in Q3 2024 was Susquehanna International Group, an estimated $3.33K added.
- The largest GeoVax Labs Warrants seller in Q3 2024 was Marex Group, an estimated $1.33K sold.
Based on aggregated 13F filings for Q3 2024.